COMMUNIQUÉS West-GlobeNewswire

Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model
19/11/2024
Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for the nine months ended September 30, for 2024 and 2023, respectively. Significantly improved [...]
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
19/11/2024
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“ Abivax ” or the “ Company ”), a clinical- [...]
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
19/11/2024
Conduit Pharmaceuticals strengthens its Board of Directors with the addition of Simon Fry, a seasoned investment banking executive with over 30 years of experience in asset management, capital markets, and strategy [...]
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
19/11/2024
REDWOOD CITY, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will [...]
Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference
19/11/2024
MENLO PARK, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, [...]
Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™
19/11/2024
Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provided further insight into its planned Phase 1 [...]
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation
19/11/2024
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced an effective date for its previously-announced share consolidation. At its Annual [...]
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference
19/11/2024
MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the [...]
Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
19/11/2024
- Alpha DaRT ® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha DaRT ® for patients with recurrent glioblastoma multiforme (GBM) - - [...]
Acentra Health’s Harish Nanda Named to Northern Virginia Technology Council’s 2024 Tech100 List of Visionary Tech Leaders and Companies
19/11/2024
NVTC also names Acentra Health among companies driving the region’s economic growth with innovative technology and AI-driven solutions MCLEAN, Va., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Acentra Health , a technology and [...]
Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024
19/11/2024
SOUTH SAN FRANCISCO, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet [...]
Conquer the New MJBizCon Expo Floor, One Pavilion at a Time
19/11/2024
DENVER, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The 13 th annual MJBizCon , the largest, most established cannabis business conference and expo in the world, opens with a more defined and inclusive expo show floor starting [...]
Helio Genomics to Host Virtual KOL Event to Discuss Recent CLiMB Trial Data and Methylation Model Score in Patients with Hepatocellular Carcinoma (HCC) on November 25, 2024
19/11/2024
IRVINE, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, today [...]
Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies
19/11/2024
ORION CORPORATION INVESTOR NEWS 19 NOVEMBER 2024 at 18.30 EET Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies Orion Corporation and Alligator Bioscience AB have agreed on the [...]
KOELIS annonce les premiers résultats provisoires de l’étude clinique VIOLETTE évaluant le recours à la technologie OBT-Fusion® dans l’ablation focale de la prostate réalisée à l’aide d’aiguilles micro-ondes
19/11/2024
GRENOBLE, France, 19 nov. 2024 (GLOBE NEWSWIRE) -- Koelis, SAS, ci-après « Koelis » ou la « Société » ( www.koelis.com ), société leader et innovante dans le domaine du traitement des maladies de la prostate, annonce ce [...]
Baylor Genetics Wins BioTech Breakthrough Award
19/11/2024
Selected as Winner of the “Overall Genomics Solution of the Year,” Recognizing the Launch of RNASeq this Year HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Baylor Genetics , a clinical diagnostic laboratory at the [...]
Synata Bio’s Sylonto Project Awarded $4.5 Million NDRC Grant
19/11/2024
The waste carbon-to-ethanol facility will transform Henan Energy Group’s on-site waste gases into 50,000 tons of ethanol per year WARRENVILLE, Ill., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Synata Bio , a U.S. company [...]
HealthEquity CMO Tia Padia Named "Visionary CMO" at MarCom Awards
19/11/2024
Award recognizes Padia’s vision to bring client and member experiences to life through an innovative, immersive experience DRAPER, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), a leader in [...]
FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
19/11/2024
HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential [...]

Pages